Tumors of the heart are very uncommon and can occur as primary or secondary metastatic tumors. Metastatic tumors are over 40 times more common than primary cardiac tumors. Primary tumors of the heart are benign in 75% of cases and malignant in 25%.1, 2 We first reported our institutional experience with all primary cardiac tumors in 2003.3 Of the 85 patients seen, 17 had malignant tumors (20%) and 68 had benign tumors (80%). These benign tumors and our subsequent experience form the basis of this report.

" /> Tumors of the heart are very uncommon and can occur as primary or secondary metastatic tumors. Metastatic tumors are over 40 times more common than primary cardiac tumors. Primary tumors of the heart are benign in 75% of cases and malignant in 25%.1, 2 We first reported our institutional experience with all primary cardiac tumors in 2003.3 Of the 85 patients seen, 17 had malignant tumors (20%) and 68 had benign tumors (80%). These benign tumors and our subsequent experience form the basis of this report.

"> Article Full Text – Methodist Journal
Methodist Journal

IN THIS ISSUE

Lipids and Lipoproteins

Vol 15, Issue 1 (2019)


FEATURED GUEST EDITOR

ISSUE INTRO

Lipids and Cardiovascular Disease: Putting it All Together

See More
RECOGNITIONS

Guest Editors Henry Pownall and Antonio Gotto Offer Insight and Expertise on the topic of Lipids and Cardiovascular Disease

See More

REVIEW ARTICLES See More

Cholesterol: Can’t Live With It, Can’t Live Without It

How Much Do Lipid Guidelines Help the Clinician? Reading Between the (Guide)lines

Statins: Then and Now

Poststatin Lipid Therapeutics: A Review

HDL and Reverse Cholesterol Transport Biomarkers

Revisiting Reverse Cholesterol Transport in the Context of High-Density Lipoprotein Free Cholesterol Bioavailability

High-Density Lipoprotein Subspecies in Health and Human Disease: Focus on Type 2 Diabetes

Gene Delivery in Lipid Research and Therapies

CASE REPORTS See More

Device-Related Thrombus: A Reason for Concern?

Retained Coronary Balloon Requiring Emergent Open Surgical Retrieval: An Uncommon Complication Requiring Individualized Management Strategies

Loperamide Mimicking Brugada Pattern

Reversed Pulsus Paradoxus in Right Ventricular Failure

MUSEUM OF HMH MULTIMODALITY IMAGING CENTER See More

Transcatheter Embolization of a Persistent Vertical Vein: A Rare Cause of Left-to-Right Shunt and Right-Sided Heart Failure

CLINICAL PERSPECTIVES See More

EXCERPTA

Talking Statins with Antonio Gotto

POINTS TO REMEMBER

Lipids and Renal Disease

EXCERPTA

Addressing the Feedback Loop Between Depression, Diabetes, and Cardiovascular Disease

POINTS TO REMEMBER

The Kidney as an Endocrine Organ

EDITORIALS

Addressing the Underrepresentation of Women in Cardiology through Tangible Opportunities for Mentorship and Leadership

Vol 6, Issue 3 (2010)

Article Full Text

REVIEW ARTICLES

Benign Cardiac Tumors: A Review

Jump to:
Article Citation:

Brian A. Bruckner and Michael J. Reardon (2010) Benign Cardiac Tumors: A Review. Methodist DeBakey Cardiovascular Journal: July 2010, Vol. 6, No. 3, pp. 20-26.

doi: https://doi.org/10.14797/mdcj-6-3-20

Abstract

Tumors of the heart are very uncommon and can occur as primary or secondary metastatic tumors. Metastatic tumors are over 40 times more common than primary cardiac tumors. Primary tumors of the heart are benign in 75% of cases and malignant in 25%.1, 2 We first reported our institutional experience with all primary cardiac tumors in 2003.3 Of the 85 patients seen, 17 had malignant tumors (20%) and 68 had benign tumors (80%). These benign tumors and our subsequent experience form the basis of this report.

Keywords
metatastic , cardiac tumor , benign

Add Comments

Please login to dialogue with author.

Comments